newsfilter
← Latest News
ACCESS Newswire·

Helix BioPharma Corp. Reports Voting Results and Appointment of New Board Director

RICHMOND HILL, ON / ACCESSWIRE / January 28, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced the voting result